Myriad Genetics Names Brian Donnelly as New Chief Commercial Officer [Yahoo! Finance]
Myriad Genetics Names Brian Donnelly as New Chief Commercial Officer
Myriad Genetics, Inc. (NASDAQ: MYGN) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Myriad Genetics, Inc. (NASDAQ: MYGN) had its price target lowered by analysts at Scotiabank from $24.00 to $20.00. They now have a "sector outperform" rating on the stock.
Myriad (MYGN) Down 17.1% Since Last Earnings Report: Can It Rebound? [Yahoo! Finance]